Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics

• المؤلفون الرئيسيون: Chongjin Zhong (مؤلف), Chao Jiang (مؤلف), Suiying Ni (مؤلف), Qizhi Wang (مؤلف), Lingge Cheng (مؤلف), Huan Wang (مؤلف), Qixiang Zhang (مؤلف), Wenyue Liu (مؤلف), Jingwei Zhang (مؤلف), Jiali Liu (مؤلف), Mulan Wang (مؤلف), Min Jin (مؤلف), Peiqiang Shen (مؤلف), Xuequan Yao (مؤلف), Guangji Wang (مؤلف), Fang Zhou (مؤلف)
• التنسيق: كتاب
• منشور في: Elsevier, 2020-09-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Shenmai injection (SMI) is a well-defined herbal preparation that is widely and clinically used as an adjuvant therapy for cancer. Previously, we found that SMI synergistically enhanced the activity of chemotherapy on colorectal cancer by promoting the distribution of drugs in xenograft tumors. Howe...